ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea
· Delayed Price · Currency is KRW 118,000
+100 (0.08%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| Raw Pharmaceutical Products | 244.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Pharmaceutical Products Growth | -2.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Clinical Trial Research | 29.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contract Clinical Trial Research Growth | -11.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| New Drugs and Generic Drug Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| Switzerland | 95.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | -3.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 84.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 112.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 59.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | -10.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 33.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -34.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium | 250.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Belgium Growth | -99.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Spain | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|